Its Fair Price: 2.98
(PBB), 3.00 (JF Apex), 3.33 (TA)
It is sitting on a profit of rm5.5 billion as group goes public.
Khazanah paid almost rm8 billion take Parkway Holdings Ltd private. The
bulk of the rm5.5 billion comes in the form of Khazanah’s 47% stake or
3.85 billion shares in IHH Healthcare Bhd post listing that comes to rm4.9
billion. Its average cost per share is rm1.58 while the IHH IPO price is rm2.85
per share. The balance of the gain comes from Khazanah’s divestment of a
portion of is stake to Mitsui Co Ltd of Japan in Feb 2011 and the sale of 60%
stake in Pantai Holdings to IHH.
Khazanah’s outlay for taking Parkway private was close to rm7.5
billion. Now (July 2012) it is sitting on a gain of rm5.5 billion, part of
which is already realized.
Khazanah took Parkway off the market in 2010 after paying S$3.5 billion
(rm8.6 billion) for the 76.1% stake it did not own. It fought a tough batter
against Fortis Healthcare group in
Singapore .
Khazanah took out the concession assets in Pantai and injected the
remaining 60% stake into IHH. It also injected 100% of IMU and 13% in Apollo
Hospital Group of India
into IHH.
In Feb 2011, Khazanah divested 30% stake of IHH to Japan Mitsui Co Ltd.
Mitsui paid rm3.3 billion for its stake. IHH’s shares were valued at rm2
in the deal. Out of the proceeds of mr3.3 billion, rm1.3 billion went to
Khazanah, which made a profit of more than rm250 million from the deal.
IHH now (July 2012) includes the company’s acquisition of a 75%
stake in Acibadem for rm3.7 billion. Acbadem is Turkey
’s largest private healthcare provider, with a network of 14 hospitals
across Turkey and
Macedonia
. Abraaj Capital, which sold the stake in Acibadem to IHH, was provided a 7.02%
stake in the latter.
Utilization Of IPO Proceeds …
IHH is offering 52 million shares or 0.65% of the enlarged share
capital to Singaporeans at S$1.18 per share and 161.14 million shares or 2% to
the Malaysian public.
IHH’s IPO will generate some rm5.13 billion in cash. The group
will allocate a lion’s share of the proceeds to reduce its whopping debts
in order to strengthen its balance sheet for future acquisition.
With the cash in hand, IHH will be able to slash its net debt to rm1.38
billion from rm6.04 billion which will reduce its gearing to 2.8 times from
current (July 2012) 7.8 times.
Its total debt
stood at around $2.4 billion as of the end of March 2012.
IHH had chosen not to commit to a dividend policy although it is
generating cash flow of rm1 billion a year. However the group will pay
dividends when appropriate.
After netting off the cost of IPO, IHH will receive about rm4.94
billion cash from the listing exercise, of which 90.9% will be used to pay off
debts. Most of the proceeds will pay off a rm3.71 billion debt for financing
the privatization of the Parkway group in 2010.
About 75% of its planned capex of rm6.9 billion has been paid for the
period between 2010 to 2015.
Its Growth …
Parkway is one of Asia’s largest private healthcare providers and
operates in Singapore ,
Malaysia , China ,
Hong Kong , India ,
Vietnam and
Brunei .
It earns more than half of its revenue in
Singapore , where it is the largest
private hospital provider with 43.9% market share.
Currently
IHH’s Singapore
operations have one of the highest margins and contribute about 28% to group
revenue.
In Malaysia ,
Parkway is the second largest private healthcare provider with a 15.1% market
share. Parkway’s expansion efforts will be focused in
Malaysia , where it intends to spend rm454
million in the next few years (2012 & Beyond) to upgrade several Pantai and
Gleaneagles hospitals in Penang, KL and the
Klang Valley
IHH aims to add 3300 new beds in the next five years to the 4900
presently (July 2012). Its core healthcare operations and investments are
located in Malaysia ,
Singapore and
Turkey . This is in addition to
other operations in China ,
India , HK, Brunei
and Macedonia .
The company diversified geographically only in recent years, as it was earnings
all its revenue from Singapore
in 2009.
IHHis vision is to be a pan Asian player in the healthcare arena. In
fact, this has panned out as planned with the acquisition of Acibedem in
addition to IHH’s foothold in
India via its 11.2% stake in Apollo
Hospitals Enterprise.
IHH will experience organic growth with the new hospitals it is
building such as its Mount Elizabeth Novena hospital complex in
Singapore .
The first investment to roll out is the Mont
Elizabeth Novena
Hospital in
Singapore in July 2012. The
hospital cost IHH rm4.5 billion to build and more than 90% has been paid for.
Nevertheless, IHH is on the lookout for hospital management agreements
within the region. IHH has HMAs in China ,
India ,
Vietnam and the Middle East .
The HMA business model allows IHH to carry on its core activity without
taking on additional investment risks, and is useful in markets which the group
is interested in but may not want to commit to right way. This is due to the
high investments and risks involved.
IHH sees HAMs as
one of the drivers of future growth for the group.
Key markets in India ,
China , Middle East and
Vietnam
are where they are looking to move the next step for the next phase of growth.
Its Shareholders …
Khazanah has decided to free the majority of the blue chips cornerstone
investors in IHH’s IPO from any trading restrictions. Only investors with
allocations of more than 50 million shares will be bound by a six month lock up
clause.
Only seven of the cornerstone investors including the EPF and the KIA
which collectively account for 900 million shares will not be able to sell
their shares in the first six months after listing set for the end of July
2012.
The EPF and KIA were given the lion’s share of the cornerstone
allotments with 8.95% and 6.71% shares on issue respectively.
Khazanah currently has a 62.14% stake in the group. The IPO will dilute
Khazanah’s stake to 47.78% but create unrealized gains of rm4.90 billion
based on its average cost of rm1.58 per share.
Khazanah will not be cashing in on IHH anytime soon. It makes up
approximately 10% of Khazanah’s portfolio and will be one of the investment’s
agency’s core businesses.
IHH next biggest shareholder is Mitsui & Co Ltd, which will have a
diluted 20.48% stake post IPO.
IHH has reserved 62 percent of its IPO for cornerstone investors who
must hold the shares for a minimum 180 days. This includes the Government of
Singapore Investment Corp, Temasek Holdings Pte’s Fullerton Fund
Management Co, Malaysian billionaire T. Ananda Krishnan’s Usaha Tegas Sdn
Bhd, Kuwait Investment Authority, asset manager Blackrock.
The 22 cornerstone investors, who also include International Finance
Corp, the private investment arm of the World Bank, will buy 1.39 billion of
the 2.23 billion shares on offer - just over a quarter of the company - the
biggest take-up by such investors of any recent major offering in the region.
Up to 1.8 billion new shares in the IPO are on offer, while Abraaj Capital will
sell 434.7 million shares in the dual Kuala Lumpur
and Singapore
listing.
Eastspring Investments, the asset management arm which is owned by
Prudential PLC, and Malaysian pension funds have already committed to invest in
the offering.
Roughly half of the remaining 720 million shares on offer will be taken
up by the MITI. The rest will be offered to retail investors as well as
employees and healthcare workers.
Of the 2.23 billion shares up for offer, about 400 million will be sold
by existing shareholders while the rest will be new issuances.
Khazanah is the largest shareholder with a 62% stake while
Japan
’s Mitsui & Co owns a 26.6% stake. Dubai based Abraaj Capital has
7.1% stake and Turkish hospital group Acibadem’s chief Mehmet Ali
Aydinlar owns 4.2% stake.
Its Valuations … dated July
2012
Its recent acquisitions may weigh down the group’s earnings with
depreciation and amortization charges. Khazanah, its major shareholder paid a
premium for its healthcare assets, as high as 26 to 30 times PER. Khazanah was
believed to have paid almost 40 times PER for the
Singapore healthcare group. Parkway
after bidding against India ’s
Fortis Group.
Khazanah’s healthcare investment arm, IHH is set to come to market at one of the
highest PER among companies making their debut on Bursa
Malaysia
. IHH already has 22 cornerstone investors lined up, a list of comprising a mix
of local and foreign, institutional and sovereign investors.
IHH’s cornerstone offering of 1.3 billion shares comprises 62.09%
of the IPO shares offerd and 17.22% of the enlarged shares capital after the
listing.
Based on the
cornerstone offer price of rm2.85, IHH is priced at 93 times pro forma FY2011
earnings per share of 3.05 sen. In comparison, the median PERs for healthcare
operators in the Asia Pacific’s emerging
markets is only 15.3 times. IHH also looks expensive compared with healthcare
service providers operating in similar markets. The median PER for five of
these players is 33.2 times (historical) and 26.1 times (forward).
No forecast was
provided in IHH’s draft prospectus released but based on pro forma EPS of
2.04 sen for the quarter ended March 31 2012 the offer price of rm2.85
translates to a PER of 34.9 times based on annualized EPS of 8.16 sen.
IHH reported pro
forma earnings of RM165 million for the 1QFY2012 ended March 31 with an
annualized earnings per share of 8.16 sen and a retail offer price of rm2.85,
the stock is being valued at 35 times earnings. The valuation appears high but
it can be justified because of the capex that will increase IHH’s 4900
beds by 63%.
However, PER may
not be the most suitable method to value the stock.
Healthcare providers are a peculiar breed, with some having aggressive
depreciation policies for their hospital equipment and other fixed assets. IHH
will be adding more than 3000 beds with the new hospitals coming onstream.
IHH should not be compared with some of the regional healthcare players
due to differing depreciation policies. Furthermore IHH offers investors an
opportunity to tap into markets where tourism healthcare is set to grow, namely
Malaysia and
Turkey
, via its indirect 60% owned Acibadem Holdings AS.
More than 90% of the RM4.9 billion in net proceeds raised from the IPO
will go paying off the capex to date (July 2012) that has been mostly funded by
debt. This leave IHH with rm1.6 billion in capex for some2200 beds to be added
by 2015.
IHH will have no problem funding the remaining capex with internally
generated funds backed by a strong cash flow of about rm1 billion annually.
The company has
also declared that it would not commit itself to a dividend policy.
Khazanah’s
acquisition of Parkway Holdings in 2010 resulted in high levels of intangibles
on IHH’s books. Due to largely to its past mergers and acquisitions,
goodwill and other intangible assets represent a substantial portion of assets.
The group’s
goodwill and other intangible were approximately rm11.6 billion as at March 31,
2012 on a historical combined basis, representing approximately 49.8% of its
total assets and 93.6% of its consolidated total equity.
Goodwill arising
from mergers and acquisitions account for most of the group’s intangibles
and are worth some rm8.5 billion, half of which can be attributed to the
Parkway Group. In total, Parkway’s intangibles are worth some rm6 billion
in IHH’s books.
IHH has been growing its global footprint, going on an acquisition
spree to capture expanding demand for healthcare services. However, almost of
the funds raised will be allocated to paying off debts used to acquire its
prized healthcare assets in the last two years (2010-2011).
IHH plans to use
90.9% of the rm6.37 billion raised from the IPO to pay off debts within 12
months. As at March 31, 2012 IHH had rm7.63 billion in total borrowings and net
gearing of 0.49 times.
The high debt levels were pinned on the group’s aggressive
expansion in the past two years (2010-2011).
The group noted that a lower gearing would give it the flexibility to
expand operations locally or overseas and to raise financing as and when
attractive opportunities arise.
In fact, IHH is not committed to a dividend policy to pay out a minimum
amount of its earnings.